Talkspace Research and Development Expenses 2020-2024 | TALK

Talkspace research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Talkspace Annual Research and Development Expenses
(Millions of US $)
2023 $18
2022 $22
2021 $16
2020 $10
2019 $12
Talkspace Quarterly Research and Development Expenses
(Millions of US $)
2024-03-31 $4
2023-12-31 $4
2023-09-30 $4
2023-06-30 $4
2023-03-31 $5
2022-12-31 $5
2022-09-30 $6
2022-06-30 $6
2022-03-31 $5
2021-12-31 $4
2021-09-30 $4
2021-06-30 $5
2021-03-31 $3
2020-12-31 $5
2020-09-30 $2
2020-06-30 $2
2020-03-31
2019-12-31
2019-09-30
2019-06-30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.477B $0.150B
Talkspace Inc. is a virtual behavioral healthcare company. It delivered services through an easy-to-use and fully encrypted web and mobile platform, consistent with HIPAA and other state regulatory requirements. The company offers treatment options for almost every need. Talkspace Inc., formerly known as Hudson Executive Investment Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $38.069B 20.90
Inspire Medical Systems (INSP) United States $4.986B 0.00
Axonics (AXNX) United States $3.440B 0.00
10x Genomics (TXG) United States $3.097B 0.00
IRhythm Technologies (IRTC) United States $3.080B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.900B 0.00
Enovis (ENOV) United States $2.801B 20.76
Azenta (AZTA) United States $2.782B 156.36
Hims & Hers Health (HIMS) United States $2.640B 0.00
Privia Health (PRVA) United States $2.144B 119.80
Schrodinger (SDGR) United States $1.652B 0.00
Omnicell (OMCL) United States $1.383B 47.81
Phreesia (PHR) United States $1.205B 0.00
Standard BioTools (LAB) United States $0.696B 0.00
Fulgent Genetics (FLGT) United States $0.651B 0.00
Definitive Healthcare (DH) United States $0.627B 0.00
Clover Health Investments (CLOV) United States $0.406B 0.00
Health Catalyst (HCAT) United States $0.378B 0.00
Pulmonx (LUNG) United States $0.326B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.306B 0.00
Butterfly Network (BFLY) United States $0.215B 0.00
P3 Health Partners (PIII) United States $0.212B 0.00
Outset Medical (OM) United States $0.159B 0.00
American Well (AMWL) United States $0.139B 0.00
TruBridge (TBRG) United States $0.129B 7.07
MSP Recovery (LIFW) United States $0.121B 0.00
Augmedix (AUGX) United States $0.109B 0.00
111 (YI) China $0.095B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.078B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.061B 0.00
EUDA Health Holdings (EUDA) Singapore $0.055B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Movano (MOVE) United States $0.043B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
CareCloud (CCLD) United States $0.020B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00